President

Michael Banfield ( Michael Banfield )

3 1 0 0

Seattle Biotech SpringStar Awarded Major Research Grant to Combat Zika

SpringStar, Inc, a Seattle biotech company, has been awarded another $1.5 million to develop new mosquito control products, this time directed at mosquitoes that transmit Zika and other viruses such as dengue, chikungunya, west Nile virus, and yellow fever. Awarded…

Metagenomics Sequencing Studies Show That the Human Skin Microbial Population Is Highly Stable—CD Genomics

Metagenomics Sequencing Studies Show That the Human Skin Microbial Population Is Highly Stable—CD Genomics

​May 11, 2016, a new study of metagenomics sequencing shows that our personal skin microbial environment remains highly stable despite frequently cleaning and exposing to rich-bacteria objects. This knowledge can be used to better understand a series of human skin…

Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever

​SpringStar, Inc, a Seattle biotech company, has stepped up their efforts to fight against mosquitoes that transmit Zika. The company’s Mosquito Trap-N-Kill™, the only EPA-registered trap of its type, targets mosquitoes that spread Zika and dengue fever. The Hawaii Department…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login